IP Verse

Frese competitive analysis

Loading summary...

Latest oppositions filed by Frese

Explore patent oppositions filed by Frese against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3236766
Product Comprising A Container And Whey ProteinCOMPAGNIE GERVAIS DANONESep 15, 2025
EP4051223
Composition Comprising Epa, Ma And Leucine For Improving Muscle FunctionNUTRICIAAug 13, 2025
EP3554250
A Method Of Producing A Dairy Concentrate With Free Divalent Cations Protein AggregationNESTLEJul 28, 2025
EP3851114
Composition Comprising Micellar Whey Protein, Vitamin D And Clacium To Improve Or Maintain MuscleNESTLEJun 24, 2025
EP3355878
Glycine For Use In Tolerance Induction In Allergic PatientsNUTRICIAJun 6, 2025
EP2662094
Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 9, 2025
EP3723503
Plant-Protein Based Texturized Oil-In-Water EmulsionsNESTLEDec 18, 2024
EP3897213
Protein Compositions With High Isoelectric ProteinsNUTRICIANov 14, 2024
EP4057824
Plant-Based MilkNESTLESep 26, 2024
EP3790405
Process For The Production Of A Food Composition With Improved Flow-AbilityNESTLESep 18, 2024

Latest patents of Frese opposed by its competitors

Explore Frese's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4076384
Oct 22, 2025Method For Producing Oil-In-Water Emulsions1
EP2854768
Jun 18, 2025Pharmaceutical Compositions Of Pemetrexed3
EP3411016
Sep 11, 2024High Caloric, High Protein Nutritional Formula1
EP3525781
Apr 24, 2024Composition Comprising Epa And Dha For An Enhanced Efficacy Of Anticancer Agents1
EP3218044
Apr 3, 2024Needleless, Intermittent, Neutral Displacement Iv Injection Port1
EP3131518
Feb 7, 2024Multichamber Bag Opening Aid1
EP3641873
Jan 10, 2024Needleless Iv Injection Port1
EP3411057
Dec 20, 2023High Caloric, High Protein Nutritional Formula Comprising Collagen1
EP3532125
Dec 13, 2023Electrical Plug For A Dialysis Machine1
EP3458121
Dec 6, 2023Flexible Tube1

Latest publications and patents of Frese New

Explore the latest publications and patents granted to Frese, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Frese

EP4076384
Oct 22, 2025Method For Producing Oil-In-Water EmulsionsGranted And Under Opposition
EP2854768
Jun 18, 2025Pharmaceutical Compositions Of PemetrexedPatent Maintained As Amended
EP3411016
Sep 11, 2024High Caloric, High Protein Nutritional FormulaGranted And Under Opposition
EP3525781
Apr 24, 2024Composition Comprising Epa And Dha For An Enhanced Efficacy Of Anticancer AgentsPatent Maintained As Amended
EP3218044
Apr 3, 2024Needleless, Intermittent, Neutral Displacement Iv Injection PortGranted And Under Opposition
EP3131518
Feb 7, 2024Multichamber Bag Opening AidPatent Maintained As Amended
EP3641873
Jan 10, 2024Needleless Iv Injection PortGranted And Under Opposition
EP3411057
Dec 20, 2023High Caloric, High Protein Nutritional Formula Comprising CollagenPatent Maintained As Amended
EP3532125
Dec 13, 2023Electrical Plug For A Dialysis MachineGranted And Under Opposition
EP3458121
Dec 6, 2023Flexible TubeGranted And Under Opposition

Latest PTAB cases involving Frese

Discover the latest PTAB cases involving Frese, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 24, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Frese

IPR2025-01268Jul 14, 2025FRESENIUS KABI SWISSBIOSIMREGENERON PHARMACEUTICALSPending
IPR2025-01269Jul 14, 2025FRESENIUS KABI SWISSBIOSIMREGENERON PHARMACEUTICALSPending
IPR2022-01065Jun 7, 2022FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHATerminated-Settled
IPR2022-00657Mar 3, 2022FRESENIUS KABI USANOVO NORDISKTerminated-Settled
IPR2022-00201Nov 24, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2021-01542Sep 24, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2021-01288Aug 18, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2021-01336Aug 18, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2021-01024Jun 28, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2021-01025Jun 28, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Frese with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
FRESENIUS KABI DEUTSCHLAND11918 - -
NESTEC3187 - -
NESTLE174220 - -
NUTRICIA159120 - -